Ken Griffin Corbus Pharmaceuticals Holdings, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.11 - $5.46 $758 - $37,657	6,897 New	6,897 $0
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $507 - $1,280	-2,416 Reduced 3.39%	68,957 $17,000
Q1 2022 May 16, 2022	SELL	$0.32 - $0.67 $311,980 - $653,208	-974,938 Reduced 93.18%	71,373 $38,000
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $505,688 - $935,523	842,814 Added 414.17%	1,046,311 $648,000
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.82 $58,148 - $104,782	57,573 Added 39.45%	203,497 $208,000
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $51,535 - $81,937	-37,076 Reduced 20.26%	145,924 $267,000
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $93,856 - $252,748	73,903 Added 67.74%	183,000 $361,000
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $1.08 Million - $2.18 Million	-1,153,750 Reduced 91.36%	109,097 $136,000
Q2 2020 Aug 14, 2020	SELL	$4.79 - $8.39 $570,599 - $999,441	-119,123 Reduced 8.62%	1,262,847 $10.6 Million
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $4.69 Million - $9.82 Million	1,362,031 Added 6830.99%	1,381,970 $7.24 Million
Q4 2019 Feb 14, 2020	SELL	$4.29 - $5.64 $480,316 - $631,465	-111,962 Reduced 84.88%	19,939 $109,000
Q1 2019 May 15, 2019	BUY	$5.76 - $8.95 $86,503 - $134,411	15,018 Added 12.85%	131,901 $0
Q4 2018 Feb 14, 2019	BUY	$5.26 - $7.97 $419,327 - $635,368	79,720 Added 214.51%	116,883 $682,000
Q3 2018 Nov 13, 2018	SELL	$4.65 - $7.95 $34,526 - $59,028	-7,425 Reduced 16.65%	37,163 $0
Q2 2018 Aug 10, 2018	BUY	$5.05 - $6.8 $116,695 - $157,134	23,108 Added 107.58%	44,588 $0
Q1 2018 May 11, 2018	BUY	$5.6 - $9.25 $17,460 - $28,841	3,118 Added 16.98%	21,480 $131,000
Q4 2017 Feb 09, 2018	BUY	$6.6 - $7.78 $121,189 - $142,856	18,362	18,362 $130,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$559,757
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$44,016
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$38,402
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account